Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts

被引:11
作者
Ryckwaert, F
Colson, P
Guillon, G
Foëx, P
机构
[1] INSERM, U469, F-34094 Montpellier, France
[2] Univ Oxford, Nuffield Dept Anaesthet, Oxford OX2 6HE, England
关键词
renin-angiotensin system; angiotensin II receptor antagonist; Langendorff; ischaemia/reperfusion; coronary flow;
D O I
10.1016/j.phrs.2004.12.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Though ischaemia/reperfusion injury induces renin-angiotensin systemic (RAS) activation and increased heart angiotensin production, the effects of blockade of the two main angiotensin 11 receptors, AT, and AT2, are not definitively established. Using a Langendorff heart preparation, effects of Valsartan 10' M (AT, receptor blocker), PD 123319 10-7 M (AT2 receptor blocker) or both in the presence of a controlled concentration of angiotensin 11 (10-8 M) in order to reproduce systemic RAS activation were studied in adult male Wistar rat heartssubmitted to ischaemia/reperfusion. Ischaemia/reperfusion impaired both systolic and diastolic function through a no-reflow phenomenon. Presence of a controlled concentration of angiotensin in the perfusate, enough to produce a significant AT, -induced vasoconstriction before ischaernia, has no relevant influence on ischaemia/reperfusion injury. Only blockade of both AT, and AT2 receptors significantly improved recovery from ischaemia; better ventricle function paralleled better perfusion. The results suggest that blockade of angiotensin 11 receptors is cumulative since blockade of AT, and AT2 receptors is more effective than blockade of just one of them. 0 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 20 条
[11]   ROLE OF LOCALLY FORMED ANGIOTENSIN-II AND BRADYKININ IN THE REDUCTION OF MYOCARDIAL INFARCT SIZE IN DOGS [J].
NODA, K ;
SASAGURI, M ;
IDEISHI, M ;
IKEDA, M ;
ARAKAWA, K .
CARDIOVASCULAR RESEARCH, 1993, 27 (02) :334-340
[12]  
SHEUER DA, 1993, AM J PHYSIOL, V264, pR917
[13]   Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats [J].
Siragy, HM ;
de Gasparo, M ;
Carey, RM .
HYPERTENSION, 2000, 35 (05) :1074-1077
[14]   Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxation [J].
Slinker, BK ;
Wu, YM ;
Brennan, AJ ;
Campbell, KB ;
Harding, JW .
CARDIOVASCULAR RESEARCH, 1999, 42 (03) :660-669
[15]   Angiotensin II type 1 (AT(1)) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo [J].
vanKats, JP ;
deLannoy, LM ;
Danser, AHJ ;
vanMeegen, JR ;
Verdouw, PD ;
Schalekamp, MADH .
HYPERTENSION, 1997, 30 (01) :42-49
[16]   Local cardiac renin-angiotensin system: Hypertension and cardiac failure [J].
Varagic, J ;
Frohlich, ED .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (11) :1435-1442
[17]   Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts [J].
Wang, QD ;
Sjöquist, PO .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 380 (01) :13-21
[18]   AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts [J].
Xu, Y ;
Kumar, D ;
Dyck, JRB ;
Ford, WR ;
Clanachan, AS ;
Lopaschuk, GD ;
Jugdutt, BI .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (04) :H1206-H1215
[19]   The AT(4) receptor agonist [Nle(1)]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart [J].
Yang, QL ;
Hanesworth, JM ;
Harding, JW ;
Slinker, BK .
REGULATORY PEPTIDES, 1997, 71 (03) :175-183
[20]   THE DELETERIOUS EFFECTS OF EXOGENOUS ANGIOTENSIN-I AND ANGIOTENSIN-II ON MYOCARDIAL ISCHEMIA-REPERFUSION INJURY [J].
YOSHIYAMA, M ;
KIM, S ;
YAMAGISHI, H ;
OMURA, T ;
TANI, T ;
TAKAGI, M ;
TODA, I ;
TERAGAKI, M ;
AKIOKA, K ;
TAKEUCHI, K ;
TAKEDA, T .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1994, 58 (05) :362-368